Chen Xueling, Yan Yongxiang, Lu Shengjun, Weng Xiufang, Liang Zhihui, Li Jianan, Zhong Maohua, Tang Jie, Xiao Wei, Sun Wei, Shen Guanxin, Wu Xiongwen
Department of Immunology, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China.
Hum Immunol. 2009 Feb;70(2):79-84. doi: 10.1016/j.humimm.2008.11.005. Epub 2008 Dec 25.
Generation and adoptive transfusion of alloreactive cytotoxic T lymphocytes (CTLs) specific for tumor are expected to circumvent tumor tolerance. Here we describe a novel protocol to raise allo-restricted, peptide-specific CTLs by co-culture of murine splenocytes and autologous macrophage bearing an allogeneic H-2K molecule associated with its restricted peptide (peptide/allo-MHC). The extracellular domains of H-2K(d) were fused with constant domains of murine IgG2a heavy chain to generate a fusion protein (peptide/H-2K(d)/IgG2aFc, the dimer) consisting of divalent TCR-ligands and an IgG Fc receptor type I (FcgammaRI)-reactive moiety. The dimer is able to bind to macrophage (Mvarphi) of H-2K(k) via the interaction of the Fc part with FcgammaRI, and cause the H-2K(k) Mvarphi to be coated with the peptide/H-2K(d) complex. The results show that proliferation of CD8+ cells is enhanced and that the specific-tetramer stained CD8+ cells appear more frequently by co-culture of H-2K(k) splenocytes with the autologous Mvarphi loaded with the dimer. Furthermore, the CD8+ T cells from the co-cultural bulk exhibit an elevated cytotoxicity against a specific target (H-2K(d)-restricted, peptide-specific cytotoxicity), compared with that against the irrelevant targets. This study provides a strategy for preparation of allo-restricted, peptide-specific CTLs, which may add to our arsenal for adoptive immunotherapy to eliminate chronic virally infected or tumor cells.
生成并过继输注针对肿瘤的同种异体反应性细胞毒性T淋巴细胞(CTL)有望克服肿瘤耐受性。在此,我们描述了一种新方案,通过将小鼠脾细胞与携带与其限制性肽相关的同种异体H-2K分子的自体巨噬细胞共培养来培养同种异体限制性、肽特异性CTL(肽/同种异体MHC)。将H-2K(d)的细胞外结构域与小鼠IgG2a重链的恒定结构域融合,以生成一种融合蛋白(肽/H-2K(d)/IgG2aFc,二聚体),其由二价TCR配体和I型IgG Fc受体(FcγRI)反应性部分组成。该二聚体能够通过Fc部分与FcγRI的相互作用与H-2K(k)的巨噬细胞(Mφ)结合,并使H-2K(k) Mφ被肽/H-2K(d)复合物包被。结果表明,通过将H-2K(k)脾细胞与负载二聚体的自体Mφ共培养,CD8+细胞的增殖增强,并且特异性四聚体染色的CD8+细胞出现得更频繁。此外,与针对无关靶标的细胞毒性相比,来自共培养群体的CD8+ T细胞对特定靶标表现出更高的细胞毒性(H-2K(d)限制性、肽特异性细胞毒性)。本研究提供了一种制备同种异体限制性、肽特异性CTL的策略,这可能会增加我们用于过继免疫疗法以消除慢性病毒感染或肿瘤细胞的手段。